Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two advertisements for TV drug ads.

Thomas Bodenheimer1

  • 1University of California, San Francisco, USA.

Health Affairs (Project Hope)
|October 7, 2003
PubMed
Summary

This study on direct-to-consumer advertising (DTCA) of pharmaceuticals has significant flaws. The research design and interpretation are weak, failing to address key questions about DTCA's health impacts.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resuscitating Primary Care: A Triad of Patient, Clinician, and AI Coach.

Family practice management·2026
Same author

Why Are Family Physicians' Panels Shrinking?

Journal of the American Board of Family Medicine : JABFM·2024
Same author

Medical Assistant Health Coaching for Type 2 Diabetes in Primary Care: Results From a Pragmatic Cluster Randomized Controlled Trial.

Diabetes care·2024
Same author

Storylines of family medicine XII: family medicine and the healthcare system.

Family medicine and community health·2024
Same author

High-Performing Teamlets in Primary Care: A Qualitative Comparative Analysis.

Journal of the American Board of Family Medicine : JABFM·2023
Same author

Making a Business Case for Team-Based Care.

Family practice management·2023

Area of Science:

  • Health communication
  • Pharmaceutical marketing
  • Medical ethics

Background:

  • Direct-to-consumer advertising (DTCA) by pharmaceutical companies is a prevalent and debated topic.
  • Concerns exist regarding potential adverse health care consequences stemming from DTCA.
  • Previous research has explored the impact of DTCA on patient-physician interactions and healthcare utilization.

Purpose of the Study:

  • To evaluate the findings and methodology of a study by Joel Weissman and colleagues on the effects of DTCA.
  • To critically assess the claims that the study's results are reassuring regarding DTCA's health care consequences.
  • To identify limitations in the study's design, interpretation, and scope.

Main Methods:

  • Critical analysis of the study's research design.
  • Evaluation of the interpretation of the collected data.
  • Assessment of the study's engagement with key unanswered questions in DTCA research.

Main Results:

  • The study by Weissman et al. exhibits significant weaknesses in its design.
  • Interpretations of the data appear overgenerous and lack critical rigor.
  • The research fails to adequately address crucial questions related to the impact of DTCA.

Conclusions:

  • The findings of the Weissman et al. study are diminished by methodological and analytical flaws.
  • The study does not provide reassuring evidence regarding the health care consequences of DTCA.
  • The research serves more as a promotional piece for drug advertising than an objective contribution to the debate.

Related Experiment Videos